As shown in Fig. 4E–G, DEX treatment strongly attenuated the ConA-induced hepatitis in mice, accompanied with fewer necrotic liver cells (Fig. 4E), lower activities of ALT and AST (Fig. 4F). The gene discussed is GPT; the disease is hepatitis A virus infection.